Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-25 Jain Nikunj Principal Accounting Officer Shares withheld for taxes −1,919 $0.17 $334 235,292
2026-05-25 Davis Gregory D Head of Research & Technology Shares withheld for taxes −1,630 $0.17 $284 113,654
2026-05-25 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −4,036 $0.17 $703 328,733
2026-05-25 Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY Shares withheld for taxes −4,036 $0.17 $703 647,370
2026-05-25 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −12,613 $0.17 $2K 1,895,043
2026-04-22 Davis Gregory D Head of Research & Technology Sale −69,827 $0.25 $18K 115,284
2026-04-21 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Sale −345,942 $0.26 $89K 332,769
2026-04-01 Jain Nikunj Principal Accounting Officer Grant or award · Stock Option (Right to Buy) +225,000 225,000
2026-04-01 Davis Gregory D Head of Research & Technology Grant or award · Stock Option (Right to Buy) +225,000 225,000
2026-04-01 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Grant or award · Stock Option (Right to Buy) +800,000 800,000
2026-04-01 Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY Grant or award · Stock Option (Right to Buy) +800,000 800,000
2026-04-01 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Grant or award · Stock Option (Right to Buy) +2,500,000 2,500,000
2026-02-25 Jain Nikunj Principal Accounting Officer Shares withheld for taxes −5,119 $0.47 $2K 237,211
2026-02-25 Davis Gregory D Head of Research & Technology Shares withheld for taxes −5,119 $0.47 $2K 185,111
2026-02-25 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −12,354 $0.47 $6K 678,711
2026-02-25 Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY Shares withheld for taxes −12,354 $0.47 $6K 651,406
2026-02-25 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −33,637 $0.47 $16K 1,907,656
2026-02-24 Jain Nikunj Principal Accounting Officer Shares withheld for taxes −666 $0.47 $315 242,330
2026-02-24 Davis Gregory D Head of Research & Technology Shares withheld for taxes −832 $0.47 $393 190,230
2026-02-24 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −2,063 $0.47 $975 691,065

Page 1 of 9 · 165 trades